[1]牛建新,李 丹,尹振宇.TCT与活检病理对早期宫颈癌及宫颈上皮内病变的诊断价值[J].医学信息,2024,37(04):139-142.[doi:10.3969/j.issn.1006-1959.2024.04.026]
　NIU Jian-xin,LI Dan,YIN Zhen-yu.Diagnostic Value of TCT and Biopsy Pathology in Early Cervical Cancer and Cervical Intraepithelial Neoplasia[J].Journal of Medical Information,2024,37(04):139-142.[doi:10.3969/j.issn.1006-1959.2024.04.026]
点击复制

TCT与活检病理对早期宫颈癌及宫颈上皮内病变的诊断价值()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年04期
页码:
139-142
栏目:
论著
出版日期:
2024-02-15

文章信息/Info

Title:
Diagnostic Value of TCT and Biopsy Pathology in Early Cervical Cancer and Cervical Intraepithelial Neoplasia
文章编号:
1006-1959（2024）04-0139-04
作者:
牛建新; 李 丹; 尹振宇
（天津市宝坻区人民医院病理科，天津 301800）
Author(s):
NIU Jian-xin; LI Dan; YIN Zhen-yu
(Department of Pathology,Tianjin Baodi District People’s Hospital,Tianjin 301800,China)
关键词:
宫颈癌; 宫颈上皮内病变; 薄层液基细胞学检查; 活检病理; 诊断一致性
Keywords:
Cervical cancer; Cervical intraepithelial neoplasia; Thinprep cytologic test; Biopsy pathology; Consistency of diagnosis
分类号:
R737.33
DOI:
10.3969/j.issn.1006-1959.2024.04.026
文献标志码:
A
摘要:
目的 探究薄层液基细胞学检查（TCT）与活检病理对早期宫颈癌及宫颈上皮内病变（CIN）的诊断价值。方法 于2021年1月-2022年12月天津市宝坻区人民医院行TCT筛查的13 000例受检者中，取阳性结果者行活检病理检查2200例，比较TCT与活检病理的诊断结果，分析二者对CIN与宫颈癌的诊断符合率、一致性与诊断价值（诊断敏感度、特异度、准确性）。结果 TCT与活检病理对CIN的诊断符合率为61.92%（805/1300），TCT与活检病理对宫颈癌的诊断符合率为79.17%（19/24）。经Kappa检验，TCT与病理活检对CIN的诊断一致性良好（Kappa=0.603，P＜0.05），TCT与病理活检对宫颈癌的诊断一致性良好（Kappa=0.728，P＜0.05）。病理活检诊断CIN与宫颈癌的敏感度、特异度、准确性均高于TCT诊断（P＜0.05）。结论 TCT与活检病理对CIN与宫颈癌的诊断结果存在较高符合率，二者诊断一致性良好，但活检病理的鉴别诊断价值更高。
Abstract:
Objective To explore the diagnostic value of thinprep cytologic test (TCT) and biopsy pathology in early cervical cancer and cervical intraepithelial neoplasia (CIN).Methods Among the 13 000 subjects who underwent TCT screening in Tianjin Baodi District People’s Hospital from January 2021 to December 2022, 2200 patients with positive results underwent biopsy pathology. The diagnostic results of TCT and biopsy pathology were compared, and the diagnostic coincidence rate, consistency and diagnostic value (diagnostic sensitivity, specificity and accuracy) of CIN and cervical cancer were analyzed.Results The coincidence rate of TCT and biopsy pathology in the diagnosis of CIN was 61.92% (805/1300), and the coincidence rate of TCT and biopsy pathology in the diagnosis of cervical cancer was 79.17% (19/24). By Kappa test, TCT and pathological biopsy had good consistency in the diagnosis of CIN (Kappa=0.603, P<0.05), TCT and pathological biopsy had good consistency in the diagnosis of cervical cancer (Kappa=0.728, P<0.05). The sensitivity, specificity and accuracy of pathological biopsy in the diagnosis of CIN and cervical cancer were higher than those of TCT (P<0.05).Conclusion TCT and biopsy pathology have a high coincidence rate in the diagnosis of CIN and cervical cancer, and the diagnostic consistency between the two is good, but the differential diagnosis value of biopsy pathology is more higher.

参考文献/References:

[1]张淑艳,武鑫瑞,王君喆,等.高危型人乳头瘤病毒检测联合液基薄层细胞学检查在宫颈病变筛查中的诊断价值分析[J].标记免疫分析与临床,2022,29(6):958-961,1051.[2]孟惠娟,陈友国,周金华,等.TCT联合HPV-DNA在宫颈癌前病变及宫颈癌的诊断价值及P16、Ki67检测的临床意义[J].临床和实验医学杂志,2022,21(6):649-652.[3]李洁,张培谊,付勇,等.HPV与TCT联合检测在宫颈癌筛查中的应用价值研究[J].人民军医,2021,64(12):1232-1234.[4]陆亚玲,张金玲,许锬,等.液基薄层细胞学、高危型人乳头瘤病毒检查在宫颈癌及癌前病变筛查中的价值[J].中华疾病控制杂志,2021,25(10):1210-1213.[5]Benard VB,Jackson JE,Greek A,et al.A population study of screening history and diagnostic outcomes of women with invasive cervical cancer[J].Cancer Med,2021,10(12):4127-4137.[6]薛雯娣,宫美丽,李旭,等.高级别宫颈上皮内瘤变及宫颈癌患者宫颈液基薄层细胞学检查和高危型人乳头状瘤病毒检测结果分析[J].中国药物与临床,2021,21(3):492-494.[7]张永臣,虞玲,吴凯华.HPV-DNA联合TCT筛查对宫颈癌的临床价值研究[J].癌症进展,2019,17(24):2994-2997.[8]黄颖.HPV、TCT联合阴道镜下宫颈活检在宫颈癌前病变中的应用[J].华夏医学,2017,30(2):70-73.[9]杨飞翔,江俊青,罗克锴,等.HPV-DNA及TCT检测在宫颈癌早期诊断中的应用[J].医学研究杂志,2020,49(11):87-90+103.[10]Alrajjal A,Pansare V,Choudhury MSR,et al.Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System[J].Cytojournal,2021,18:16.[11]Hodgson A,Olkhov-Mitsel E,Howitt BE,et al.International Endocervical Adenocarcinoma Criteria and Classification (IECC): correlation with adverse clinicopathological features and patient outcome[J]. Journal of Clinical Pathology, 2019,72(5):347-353.[12]李娜.联合检测TCT与阴道镜在宫颈癌前病变诊断中的价值分析[J].河北医学,2019,25(12):2071-2075.[13]Parker JE,Holloway SB,Miller DS,et al.Association between elapsed time after initial diagnosis and outcomes in patients diagnosed with early stage cervical cancer at a safety net hospital - ScienceDirect[J].Gynecologic Oncology,2020,159(2):9-10.[14]李丽娟,张秋菊,樊素珍.TCT联合HR-HPV检测在宫颈癌及癌前病变早期筛查中的应用价值[J].癌症进展,2019,17(21):2569-2571,2601.[15]欧丽滢,刘浩,陈茵,等.TCT与HPV E6/E7 mRNA定量检测筛查对宫颈癌及癌前病变患者的临床价值[J].广西医科大学学报,2019,36(10):1614-1618.[16]闫琼琼,王晓娟.TCT、HPV联合阴道镜在宫颈癌前病变筛查中的应用价值[J].实用癌症杂志,2019,34(7):1104-1106.[17]李常虹,张林静,聂明朝,等.早期宫颈上皮内瘤变患者HPV、TCT检查的临床价值分析[J].中国性科学,2019,28(5):56-59.[18]刘鸣.阴道镜下宫颈活检联合宫颈环形电切术在宫颈病变诊治中的应用价值[J].中国医药导报,2019,16(8):96-99.[19]李琪.液基细胞学、阴道镜组织活检和HPV-DNA检测防治宫颈癌前病变的价值研究[J].中国妇幼保健,2018,33(15):3578-3580.[20]张功学,丁凯,齐峰,等.液基脱落细胞学检查联合HPV及P16检查在宫颈癌早期诊断中的对比研究[J].中国卫生检验杂志,2018,28(7):851-854.[21]纪巧云,邓巧玲,郑朝晖.液基细胞学检查在宫颈癌筛查中的临床应用价值[J].中国妇幼保健,2018,33(7):1495-1498.[22]Pontes VB,Martins L,Szklo M,et al.Factors associated with cervical intraepithelial neoplasia (CIN2/CIN3), early stage and advanced stage of cervical cancer diagnosis in the Brazilian Amazonian region[J].European Journal of Cancer Prevention,2020,29(4):342-345.[23]杜祯,陈锡山,盛赠美.宫颈癌及宫颈上皮内瘤变患者宫颈液基薄层细胞学检查及高危型人乳头瘤病毒检测的临床价值[J].实用临床医药杂志,2020,24(17):24-27.[24]曲首辉,鲍志敏,刘荣欣.TCT、活检病理在宫颈上皮瘤变及早期宫颈癌诊断中的价值分析[J].天津医科大学学报,2018,24(4):360-362.[25]邵玮,李敬巍.宫颈薄层液基细胞学联合高危型人乳头瘤病毒检测对老年宫颈癌前病变及宫颈癌的诊断价值分析[J].老年医学与保健,2020,26(4):618-621.[26]罗晶,李婷婷,王倩,等.液基薄层细胞学检查、人乳头状瘤病毒检测及阴道镜检查在宫颈癌前病变及宫颈癌筛查中的应用价值[J].新乡医学院学报,2021,38(5):427-430,435.[27]卢颖,罗喜平,李屹,等.阴道镜下宫颈活检和宫颈LEEP术后病理检查对宫颈上皮内瘤变的诊断价值[J].中国生育健康杂志,2021,32(1):50-53.

相似文献/References:

[1]廖加群,曹 雪,陈燕平,等.宫颈癌盆腔淋巴结转移分布及危险因素分析[J].医学信息,2018,31(03):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
　LIAO Jia-qun,CAO Xue,CHEN Yan-ping,et al.Distribution and Risk Factors of Pelvic Lymph Node Metastasis in Cervical Cancer[J].Journal of Medical Information,2018,31(04):25.[doi:10.3969/j.issn.1006-1959.2018.03.008]
[2]徐 洁.宫颈癌筛查及预防的研究进展[J].医学信息,2018,31(09):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
　XU Jie.Advances in Screening and Prevention of Cervical Cancer[J].Journal of Medical Information,2018,31(04):70.[doi:10.3969/j.issn.1006-1959.2018.09.022]
[3]黄 花,徐冬冬,章丽霞.TGF-β1在宫颈癌中的研究进展[J].医学信息,2018,31(12):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
　HUANG Hua,XU Dong-dong,ZHANG Li-xia.Research Progress of TGF-β1 in Cervical Cancer[J].Journal of Medical Information,2018,31(04):31.[doi:10.3969/j.issn.1006-1959.2018.12.011]
[4]夏易曼娜,李虎成.腹腔镜下宫颈癌根治术与传统开腹手术的对比研究[J].医学信息,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
　XIA Yi-manna,LI Hu-cheng.Comparative Study of Laparoscopic Radical Resection of Cervical Cancer and Traditional Open Surgery[J].Journal of Medical Information,2018,31(04):115.[doi:10.3969/j.issn.1006-1959.2018.12.036]
[5]杨 军,王翠平,李 龙,等.义安区体检HPV-DNA筛查结果分析[J].医学信息,2018,31(14):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
　YANG Jun,WANG Cui-ping,LI Long,et al.Analysis of the Results of HPV-DNA Screening in the Medical Examination of Yian District[J].Journal of Medical Information,2018,31(04):136.[doi:10.3969/j.issn.1006-1959.2018.14.041]
[6]王双英,张 娜,刘 芳.具有高危复发因素的早期宫颈癌术后辅助治疗进展[J].医学信息,2018,31(15):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
　WANG Shuang-ying,ZHANG Na,LIU Fang.Advances in Postoperative Adjuvant Therapy for Early Cervical Cancer with High Risk of Recurrence[J].Journal of Medical Information,2018,31(04):33.[doi:10.3969/j.issn.1006-1959.2018.15.012]
[7]聂小凤,翟慧慧,冷天艳,等.宫颈脱落细胞miR34a检测在HR-HPV阳性患者 分流中的作用分析[J].医学信息,2018,31(16):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
　NIE Xiao-feng,ZHAI Hui-hui,LENG Tian-yan,et al.Analysis of the Role of MiR34a in Cervical Exfoliated Cells in Shunt of HR-HPV Positive Patients[J].Journal of Medical Information,2018,31(04):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
[8]吴晓玲,周桂华.miR-187在宫颈癌中的表达与临床病理关系的研究[J].医学信息,2018,31(16):69.[doi:10.3969/j.issn.1006-1959.2018.16.019]
　WU Xiao-ling,ZHOU Gui-hua.Expression of miR-187 in Cervical Cancer and Its Relationship with Clinicopathological Features[J].Journal of Medical Information,2018,31(04):69.[doi:10.3969/j.issn.1006-1959.2018.16.019]
[9]夏为书,彭莉贞,钟清玲.我国宫颈癌患者配偶生活质量评价的研究现状[J].医学信息,2018,31(23):41.[doi:10.3969/j.issn.1006-1959.2018.23.012]
　XIA Wei-shu,PENG Li-zhen,ZHONG Qing-ling.Research Status of Spouse Quality of Life Evaluation of Cervical Cancer Patients in China[J].Journal of Medical Information,2018,31(04):41.[doi:10.3969/j.issn.1006-1959.2018.23.012]
[10]邢 均.全身麻醉联合硬膜外麻醉在宫颈癌手术中的应用及效果评价[J].医学信息,2019,32(01):122.[doi:10.3969/j.issn.1006-1959.2019.01.037]
　XING Jun.Application and Evaluation of General Anesthesia Combined with Epidural Anesthesia in[J].Journal of Medical Information,2019,32(04):122.[doi:10.3969/j.issn.1006-1959.2019.01.037]
[11]张 晴,杨勇莉.p16在宫颈癌发生发展中的作用[J].医学信息,2022,35(01):59.[doi:10.3969/j.issn.1006-1959.2022.01.014]
　ZHANG Qing,YANG Yong-li.Role of p16 in the Development of Cervical Cancer[J].Journal of Medical Information,2022,35(04):59.[doi:10.3969/j.issn.1006-1959.2022.01.014]

更新日期/Last Update: 1900-01-01